Pietro Iaffaldano

3.4k total citations
56 papers, 898 citations indexed

About

Pietro Iaffaldano is a scholar working on Pathology and Forensic Medicine, Oncology and Rheumatology. According to data from OpenAlex, Pietro Iaffaldano has authored 56 papers receiving a total of 898 indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pathology and Forensic Medicine, 16 papers in Oncology and 12 papers in Rheumatology. Recurrent topics in Pietro Iaffaldano's work include Multiple Sclerosis Research Studies (48 papers), Polyomavirus and related diseases (13 papers) and Peripheral Neuropathies and Disorders (9 papers). Pietro Iaffaldano is often cited by papers focused on Multiple Sclerosis Research Studies (48 papers), Polyomavirus and related diseases (13 papers) and Peripheral Neuropathies and Disorders (9 papers). Pietro Iaffaldano collaborates with scholars based in Italy, Australia and Switzerland. Pietro Iaffaldano's co-authors include María Trojano, Rosa Gemma Viterbo, Maria Pia Amato, Damiano Paolicelli, Benedetta Goretti, Emilio Portaccio, Vita Direnzo, Bahia Hakiki, Tim Spelman and Claudia Niccolai and has published in prestigious journals such as PLoS ONE, Neurology and International Journal of Molecular Sciences.

In The Last Decade

Pietro Iaffaldano

51 papers receiving 886 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pietro Iaffaldano Italy	18	705	197	195	139	114	56	898
Benjamin Turner United Kingdom	14	687 1.0×	298 1.5×	239 1.2×	195 1.4×	120 1.1×	42	933
Lívia Sousa Portugal	16	545 0.8×	183 0.9×	123 0.6×	99 0.7×	84 0.7×	59	741
James Stankiewicz United States	16	584 0.8×	253 1.3×	122 0.6×	143 1.0×	161 1.4×	27	960
Mark Wardle United Kingdom	15	585 0.8×	359 1.8×	124 0.6×	139 1.0×	177 1.6×	35	972
Channa Kolb United States	21	807 1.1×	301 1.5×	144 0.7×	199 1.4×	134 1.2×	50	1.2k
Eva Strijbis Netherlands	17	674 1.0×	231 1.2×	223 1.1×	108 0.8×	145 1.3×	98	1.0k
Aurora Zanghì Italy	16	462 0.7×	169 0.9×	174 0.9×	117 0.8×	87 0.8×	50	648
Luciana Midaglia Spain	16	687 1.0×	326 1.7×	113 0.6×	178 1.3×	89 0.8×	44	892
Marc Coustans France	10	689 1.0×	338 1.7×	249 1.3×	197 1.4×	78 0.7×	10	878
George J. Hutton United States	14	619 0.9×	213 1.1×	188 1.0×	133 1.0×	116 1.0×	46	865

Countries citing papers authored by Pietro Iaffaldano

Since Specialization

Citations

This map shows the geographic impact of Pietro Iaffaldano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pietro Iaffaldano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pietro Iaffaldano more than expected).

Fields of papers citing papers by Pietro Iaffaldano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pietro Iaffaldano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pietro Iaffaldano. The network helps show where Pietro Iaffaldano may publish in the future.

Co-authorship network of co-authors of Pietro Iaffaldano

This figure shows the co-authorship network connecting the top 25 collaborators of Pietro Iaffaldano. A scholar is included among the top collaborators of Pietro Iaffaldano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pietro Iaffaldano. Pietro Iaffaldano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Copetti, Massimiliano, et al.. (2025). Refining Prognostic Factors in Adult-Onset Multiple Sclerosis: A Narrative Review of Current Insights. International Journal of Molecular Sciences. 26(16). 7756–7756.

Copetti, Massimiliano, Chiara Zanetta, Francesco Patti, et al.. (2025). The Italian Multiple Sclerosis Register Experience With Cladribine. Neurology Neuroimmunology & Neuroinflammation. 12(4). e200415–e200415.

Iaffaldano, Pietro, et al.. (2025). A Window into New Insights on Progression Independent of Relapse Activity in Multiple Sclerosis: Role of Therapies and Current Perspective. International Journal of Molecular Sciences. 26(3). 884–884. 2 indexed citations

Caputo, Francesca, et al.. (2024). Siponimod from fingolimod direct switch in patients transitioning in secondary progressive multiple sclerosis: A single center case series. Clinical Neurology and Neurosurgery. 245. 108475–108475. 1 indexed citations

Mallucci, Giulia, Ottavia Eleonora Ferraro, María Trojano, et al.. (2024). Early prediction of unfavorable evolution after a first clinical episode suggestive of multiple sclerosis: the EUMUS score. Journal of Neurology. 271(6). 3496–3505.

Chisari, Clara Grazia, Maria Pia Amato, Alessia Di Sapio, et al.. (2024). Active and non-active secondary progressive multiple sclerosis patients exhibit similar disability progression: results of an Italian MS registry study (ASPERA). Journal of Neurology. 271(10). 6801–6810. 4 indexed citations

Arun, Tarunya, C. Capela, Guy Laureys, et al.. (2023). Influence of physicians’ risk perception on switching treatments between high- efficacy and non–high-efficacy disease‑modifying therapies in multiple sclerosis. Multiple Sclerosis and Related Disorders. 76. 104770–104770. 3 indexed citations

Filippi, Massimo, Giovanna Borriello, Francesco Patti, et al.. (2023). Perspectives on Neuromyelitis Optica Spectrum Disorders, the Narrative Medicine contribution to care. Neurological Sciences. 45(4). 1589–1597. 1 indexed citations

Iaffaldano, Pietro, Giuseppe Lucisano, Helmut Butzkueven, et al.. (2021). Early treatment delays long-term disability accrual in RRMS: Results from the BMSD network. Multiple Sclerosis Journal. 27(10). 1543–1555. 36 indexed citations

10.

Hillert, Jan, Melinda Magyari, Per Soelberg Sørensen, et al.. (2021). Treatment Switching and Discontinuation Over 20 Years in the Big Multiple Sclerosis Data Network. Frontiers in Neurology. 12. 647811–647811. 18 indexed citations

11.

Trojano, María, et al.. (2021). Dengue fever in a multiple sclerosis patient taking Ocrelizumab. Multiple Sclerosis Journal. 27(13). 2116–2118. 2 indexed citations

12.

Caputo, Francesca, et al.. (2021). Effectiveness and safety of ocrelizumab in a real-world setting: A single center experience from southern italy. Journal of the Neurological Sciences. 429. 117790–117790. 1 indexed citations

13.

Lepore, Vito, Cristina Bosetti, Claudia Santucci, et al.. (2020). Detection of disability worsening in relapsing‐remitting multiple sclerosis patients: a real‐world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register. European Journal of Neurology. 28(2). 567–578. 7 indexed citations

14.

Lucisano, Giuseppe, Mariangela D’Onghia, Domenico Maria Mezzapesa, et al.. (2019). Lymphocyte Count and Body Mass Index as Biomarkers of Early Treatment Response in a Multiple Sclerosis Dimethyl Fumarate-Treated Cohort. Frontiers in Immunology. 10. 1343–1343. 10 indexed citations

15.

Simone, Marta, Rosa Gemma Viterbo, Lucia Margari, & Pietro Iaffaldano. (2018). Computer-assisted rehabilitation of attention in pediatric multiple sclerosis and ADHD patients: a pilot trial. BMC Neurology. 18(1). 82–82. 33 indexed citations

16.

Paolicelli, Damiano, Martina D’Onghia, Vita Direnzo, et al.. (2016). Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patients. Journal of Neuroimmunology. 303. 75–80. 12 indexed citations

17.

Goretti, Benedetta, Rosa Gemma Viterbo, Emilio Portaccio, et al.. (2013). Anxiety state affects information processing speed in patients with multiple sclerosis. Neurological Sciences. 35(4). 559–563. 53 indexed citations

18.

Zoccolella, Stefano, Carla Tortorella, Pietro Iaffaldano, et al.. (2012). Low Serum Urate Levels Are Associated to Female Gender in Multiple Sclerosis Patients. PLoS ONE. 7(7). e40608–e40608. 20 indexed citations

19.

Tortorella, Carla, Maddalena Ruggieri, E. Di Monte, et al.. (2011). Serum and CSF N-acetyl aspartate levels differ in multiple sclerosis and neuromyelitis optica. Journal of Neurology Neurosurgery & Psychiatry. 82(12). 1355–1359. 20 indexed citations

20.

Trojano, María, Damiano Paolicelli, Aurora Fuiani, et al.. (2008). Postmarketing evidence of disease-modifying drugs in multiple sclerosis. Neurological Sciences. 29(S2). 225–226. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact